35
17
th
Congress of the European Society for Sexual Medicine
Poster Presentations
041 Impact of treatments for lower urinary tract
symptoms/benign prostatic hyperplasia on eja-
culation
Kim Drasa, Albania
E. Dani
042 Does still is a place for paroxetine in the era of
dapoxetine
Aleksander Khelaia, Georgian
L. Managadze, Z. Marshania
043 Hemiscrotal orgasmic pain treated by phospho-
diesterase 5 inhibition
Nabeel Kuwaijo, Ireland
P. Hegarty, H. Hegarty, N. Hegarty, K. O´Malley
044 Anejaculatory orgasm: Dilemmas in management
Sanjay Pandey, India
045 Paroxetine treatment does not effect testicular
histology in rats
Ege Can Serefoglu, Turkey
A. Gul, S. Altinay, D. S. Celik, A. Colakerol,
E. Yuruk
046 Evaluation of the fertility status of patients with
lifelong premature ejaculation who were admit-
ted to urology outpatient clinic
Ege Can Serefoglu, Turkey
A. Colakerol, S. Calhan, E. Yuruk, M. Dincer
047 Sensate focus exercise in newly-married men
who ejaculates before intercourse
Hongxiang Wang, China
T. Zhang, B. Chen, Y. Han, Y. Wang, Y. Huang
048 Desensitization treatment for primary PE
Hongxiang Wang, China
B. Chen, T. Zhang, Y. Han, Y. Wang, Y. Huang
049 Over-sensitivity, a domain should not be ignore
in PE
Tao Zhang, China
Q. Yang, B. Chen, Y. Huang, Y. Huang, P. Ping,
X. Chen, H. Wang, K. Hu, Y. Jin, Y. Wang,
Y. Huang
050 Combination of tamsulin (0.4 mg) and dutas-
teride (5 mg) for benign prostatic hyperplasia.
Objective analysis of stromal components of the
transition zone
Andre Cavalcanti, Brazil
F. Sampaio, F. Restrepo, C. Gallo, B. Pereira,
N. Machado, W. Costa
051 Improvement in both lower urinary tract symp-
toms and erectile function with alpha blocker
therapy in benign prostatic hyperplasia
Christopher Ho, Malaysia
N. Ahmad Nazir, Z. Md Zainuddin
052 Quantitative and qualitative analyses of stromal
and acinar components of prostate zones
Bruno Marroig, Brazil
F. Sampaio, B. Gregorio, C. Gallo, E. Alves,
W. Costa
053 Clinical correlates of enlarged prostate size in
subjects with sexual dysfunction
Elisa Maseroli, Italy
G. Corona, M. Gacci, G. Rastrelli, L. Vignozzi,
A. Sforza, G. Forti, E. Mannucci, M. Maggi
054 Characteristics of compensated hypogonadism
in patients with sexual dysfunction
Elisa Maseroli, Italy
G. Corona, G. Rastrelli, A. Sforza, G. Forti,
E. Mannucci, M. Maggi
055 Semen quality assessment in fertile men in
spain during the last three decades
José Medina-Polo, Spain
R.-O. Javier, B. García-Gómez, L.-P. David,
E. Jiménez-Alcaide, L. García-González,
A. Arrébola-Pajares, A. Rodríguez-Antolín,
E. García Cruz
056 The prostate after castration and hormone repla-
cement in a rat model: Structural and ultrastruc-
tural analysis
Alexandre Miranda, Brazil
B. Felix-Patricio, B. Gregorio, C. Gallo,
D. Benchimol, W. Costa, F. Sampaio
057 Development and recovery from secondary hypo-
gonadism in aging men: Risk factors and clinical
features. Prospective results from the european
male aging study (EMAS)
Giulia Rastrelli, Italy
E. Carter, J. Finn, S. Pye, M. Rutter,
I. Huhtaniemi, N. Pendleton, G. Forti,
M. Maggi, F. Wu
058 Orgasmic function relies on testosterone levels –
results of a cross-sectional study in men seeking
medical attention for erectile dysfunction
Eugenio Ventimiglia, Italy
P. Capogrosso, L. Boeri, A. Serino, G. La Croce,
G. Castagna, A. Pecoraro, M. Paciotti, R. Sca-
no, F. Montorsi, A. Salonia
059 Development of a multivariate logistic regres-
sion-based nomogram to predict the presence
of hypogonadism in patients with new-onset
erectile dysfunction
Eugenio Ventimiglia, Italy
P. Capogrosso, L. Boeri, A. Serino, G. La
Croce, G. Castagna, A. Pecoraro, M. Paciotti,
R. Scano, F. Montorsi, A. Salonia
